Donate | Español
May 31, 2011 - Higher prescription co-payments are associated with noncompliance with hormonal therapy for breast cancer, according to a study published online May 23 in the Journal of Clinical Oncology.
May 31, 2011
View More News
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!